Welcome to UK & Ireland’s Website

Henkel delivers overall robust performance in fiscal 2020 despite substantial impact from COVID-19 pandemic

• Balanced portfolio, strong innovations, financial strength, and dedicated team as key enablers for robust business performance in a global crisis
• 2020 results at upper end of full-year guidance:
  • Group sales reach 19.3 billion euros, organic: -0.7 percent
  • EBIT margin* at 13.4 percent, -260 basis points, corresponding to an operating profit* of 2.6 billion euros
  • Earnings per preferred share ‏(EPS)*: 4.26 euros, -17.9 percent at constant exchange rates
• Very strong free cash flow of 2.3 billion euros, net financial position significantly improved
• Proposed dividend on prior-year level: 1.85 euros per preferred share
• Implementation of agenda for purposeful growth on track, clear roadmap for further execution in 2021 and beyond
• Outlook for 2021:
  • Organic sales growth: 2.0 to 5.0 percent
  • EBIT margin*: 13.5 to 14.5 percent
  • Earnings per preferred share ‏(EPS)*: an increase between 5.0 to 15.0 percent at constant exchange rates

Strong track record and ambitious sustainability targets for 2025

• Henkel publishes 30th Sustainability Report
• Strong improvements in all sustainability dimensions since 2010
• Ambitious targets for 2025

€1m partnership between Henkel, DeRoyal, Tyndall & RCSI aims to transform compression wound therapy

Henkel is part of a consortium that expects to significantly advance the treatment of non-healing chronic wounds through the development of smart wound care technology.